CDRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CDRE is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive signals from analyst Buy ratings, positive congress buying, and a bullish options skew, but the current technical setup is mixed and the latest quarterly financials showed declining revenue, EPS, and net income. With no AI Stock Picker or SwingMax signal today, I would not call this an immediate buy. Best direct read: hold and wait for clearer confirmation after upcoming Q1 results.
Price closed at 29.65, right around the pivot level of 29.673, which suggests the stock is sitting at a decision point rather than a strong breakout. MACD histogram is slightly positive and expanding, which is constructive, but RSI_6 at 48.9 is neutral and does not show strong momentum. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still weak. Support sits at 27.831 and 26.694, while resistance is at 31.514 and 32.651. Overall, the chart is mixed-to-bearish with early stabilization, not a clean long-term entry yet.
["Jefferies kept a Buy rating and said the recent pullback creates a buying opportunity.", "Lake Street and Roth Capital both raised price targets and kept Buy ratings after the TYR Tactical acquisition closed.", "Congress trading data shows 1 purchase and 0 sales in the last 90 days, indicating positive institutional/political interest.", "Options sentiment is bullish with low put-call ratios and call-heavy activity.", "Upcoming Q1 2026 earnings and conference call may serve as a catalyst if results improve."]
["Jefferies cut its price target from $55 to $45 after Cadre missed Q4 earnings estimates by 36%.", "Fiscal 2025 nuclear safety revenue declined 7%, showing weakness in a core segment.", "Latest quarter financials were negative across revenue, net income, EPS, and gross margin.", "Technical trend remains bearish on the moving averages.", "No AI Stock Picker signal and no recent SwingMax entry signal."]
In Q4 2025, Cadre's revenue fell 4.98% YoY to $167.2M, net income declined 9.58% YoY to $11.7M, EPS dropped 28.12% YoY to $0.23, and gross margin slipped to 43.43% from the prior year. The latest quarter therefore shows slowing growth and weaker profitability. This is not the kind of earnings profile that supports an immediate aggressive long-term buy without better confirmation.
Analyst sentiment is still positive overall, but the trend is mixed. Jefferies lowered its target to $45 from $55 while maintaining Buy, citing the Q4 miss and weaker nuclear safety revenue. Earlier in February, Lake Street raised its target to $53 from $49 and Roth Capital raised its target to $50 from $49, both keeping Buy ratings after the TYR Tactical acquisition. Wall Street’s pros view is that the acquisition strengthens Cadre’s growth and margin profile and the core story remains intact. The cons view is that recent earnings and segment revenue weakness show execution pressure and slower growth, which is why one firm reduced its target.
